Methoblastin; Maxtrex; Methotrexat; Lantarel; Trexan

SECTION 2: Hazards identification

Appearance: Clear yellow solution

Hazard statements

Non-hazardous in accordance with international standards for workplace safety.

Additional information

Short Term: May be absorbed through the skin and cause systemic effects. May be harmful if swallowed. (based on components) . Long Term: Animal studies have shown a potential to cause adverse effects on the fetus. The use of this drug during pregnancy has resulted in birth defects. Known Clinical Effects: Adverse effects associated with therapeutic use include gastrointestinal disturbances such as nausea, dyspepsia, and vomiting and gastrointestinal irritation. Effects on blood and blood- forming organs have also occurred. EU Indication of danger: Not classified Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.